董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Timothy Warbington | 男 | Chief Executive Officer and Director and President | 64 | 73.27万美元 | 4.08 | 2025-10-30 |
| Donald Dickerson | 男 | Chief Financial Officer and Director and Senior Vice President | 60 | 56.00万美元 | 0.83 | 2025-10-30 |
| Michael H. Finger | 男 | Director | 78 | 8.00万美元 | 0.04 | 2025-10-30 |
| Susan Snow | 女 | Director | 68 | 12.00万美元 | 未持股 | 2025-10-30 |
| Bruce S. Urdang | 男 | Director | 67 | 10.00万美元 | 未持股 | 2025-10-30 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Timothy Warbington | 男 | Chief Executive Officer and Director and President | 64 | 73.27万美元 | 4.08 | 2025-10-30 |
| Donald Dickerson | 男 | Chief Financial Officer and Director and Senior Vice President | 60 | 56.00万美元 | 0.83 | 2025-10-30 |
董事简历
中英对照 | 中文 | 英文- Timothy Warbington
-
Timothy Warbington自2016年2月起担任我们的董事兼首席执行官，自2011年10月起担任CMH的董事，首席执行官兼总裁。他拥有超过25年的管理经验。Warbington先生于1984年获得亚利桑那州立大学的会计学士学位。从1993年到2007年，他拥有并经营一家数百万美元的国家农产品和金融公司，年收入为5000000美元至12000000美元。在此之前，他担任一家从事国际食品贸易的英国公司的美国子公司的首席运营官。八年来，Warbington先生一直投资于生物技术行业，并作为一家上市生物技术公司的顾问提供战略和战术建议。
Timothy Warbington has served as director and as Chief Executive Officer since February 2016 and has served as a director, Chief Executive Officer and President of an affiliate of predecessor, Creative Medical Health, Inc. ("CMH") since October 2011. He has over 25 years of executive level management experience. Mr. Warbington received a Bachelor's Degree in Accounting from Arizona State University in 1984. From 1993 through 2007 he owned and operated a multi million dollar national agricultural (produce) and finance company with annual revenues of $5,000,000 to $12,000,000. Prior to that, he served as Chief Operating Officer of the U.S. subsidiary of a British firm engaged in the international food trade. For eight years, Mr. Warbington has invested in the biotechnology indtry and has provided strategic and tactical advice as a consultant to a publicly traded bio tech firm. In connection with this experience, he has built a network of scientists, physicians and executives to participate as executive officers and directors of CMH. - Timothy Warbington自2016年2月起担任我们的董事兼首席执行官，自2011年10月起担任CMH的董事，首席执行官兼总裁。他拥有超过25年的管理经验。Warbington先生于1984年获得亚利桑那州立大学的会计学士学位。从1993年到2007年，他拥有并经营一家数百万美元的国家农产品和金融公司，年收入为5000000美元至12000000美元。在此之前，他担任一家从事国际食品贸易的英国公司的美国子公司的首席运营官。八年来，Warbington先生一直投资于生物技术行业，并作为一家上市生物技术公司的顾问提供战略和战术建议。
- Timothy Warbington has served as director and as Chief Executive Officer since February 2016 and has served as a director, Chief Executive Officer and President of an affiliate of predecessor, Creative Medical Health, Inc. ("CMH") since October 2011. He has over 25 years of executive level management experience. Mr. Warbington received a Bachelor's Degree in Accounting from Arizona State University in 1984. From 1993 through 2007 he owned and operated a multi million dollar national agricultural (produce) and finance company with annual revenues of $5,000,000 to $12,000,000. Prior to that, he served as Chief Operating Officer of the U.S. subsidiary of a British firm engaged in the international food trade. For eight years, Mr. Warbington has invested in the biotechnology indtry and has provided strategic and tactical advice as a consultant to a publicly traded bio tech firm. In connection with this experience, he has built a network of scientists, physicians and executives to participate as executive officers and directors of CMH.
- Donald Dickerson
-
Donald Dickerson自2016年2月起担任我们的董事，首席财务官兼高级副总裁，自2014年6月起担任CMH的董事，副总裁兼首席运营官。他于1992年5月获得南加州大学的金融工商管理硕士学位。Dickerson先生曾担任多个管理和会计职位，并在技术，制造和健康科学领域的公司拥有经验。从2003年10月到2009年2月，他曾担任JP Morgan Chase公司的财务副总裁；从2011年6月到2014年5月，他还担任Medistem，Inc.的首席财务官。
Donald Dickerson has served as director and as Chief Financial Officer and Senior Vice President since February 2016, and has served as a director and as Vice President and Chief Operating Officer of CMH since June 2014. He received his Masters of Biness Administration in Finance from the University of Southern California in May 1992. Mr. Dickerson has worked in a number of management and accounting positions and has experience with companies in the technology, manufacturing and health sciences area. From October 2003 until February 2009 he was employed as a vice president for JP Morgan Chase in finance; from March 2009 until May 2014 he served as a director for GMT Ventures in finance and operations; and from June 2011 until May 2014 he also served as CFO for Medistem, Inc. - Donald Dickerson自2016年2月起担任我们的董事，首席财务官兼高级副总裁，自2014年6月起担任CMH的董事，副总裁兼首席运营官。他于1992年5月获得南加州大学的金融工商管理硕士学位。Dickerson先生曾担任多个管理和会计职位，并在技术，制造和健康科学领域的公司拥有经验。从2003年10月到2009年2月，他曾担任JP Morgan Chase公司的财务副总裁；从2011年6月到2014年5月，他还担任Medistem，Inc.的首席财务官。
- Donald Dickerson has served as director and as Chief Financial Officer and Senior Vice President since February 2016, and has served as a director and as Vice President and Chief Operating Officer of CMH since June 2014. He received his Masters of Biness Administration in Finance from the University of Southern California in May 1992. Mr. Dickerson has worked in a number of management and accounting positions and has experience with companies in the technology, manufacturing and health sciences area. From October 2003 until February 2009 he was employed as a vice president for JP Morgan Chase in finance; from March 2009 until May 2014 he served as a director for GMT Ventures in finance and operations; and from June 2011 until May 2014 he also served as CFO for Medistem, Inc.
- Michael H. Finger
-
Michael H.Finger已同意在本次发行结束时担任董事。Finger先生是他于2017年创立的房地产咨询公司Alternative Sales Source，LLC的经理兼主要成员。在创立Alternative Sales Source，LLC之前，Finger先生是相关公司Hyland Bay Systems（他是该公司的首席财务官）和Hyland Bay Realty（他在2016年出售了这两家公司）的创始人和主要股东。Finger先生还创立了Cardinal Financial Services，Inc.，这是一家全国性的商业房地产抵押贷款经纪公司，他在该公司运营了20多年，直到2007年该公司被出售。Finger先生在哥伦比亚大学获得金融工商管理硕士学位，并在波士顿大学获得生物学学士学位。
Michael H. Finger has served as a director of s since December 2021.Mr. Finger is the manager and principal member of Alternative Sales Sce, LLC, a real estate consulting firm that he founded in 2017. Prior to founding Alternative Sales Sce, LLC, Mr. Finger was active as the founder and principal shareholder of the related companies, Hyland Bay Systems, of which he was Chief Financial Officer, and Hyland Bay Realty, both of which he sold in 2016. Mr. Finger also founded Cardinal Financial Services, Inc., a national commercial real estate mortgage brokerage firm that he operated for over 20 years until its sale in 2007. Mr. Finger received his MBA in finance from Colombia University and holds a B.A. in biology from Boston University. - Michael H.Finger已同意在本次发行结束时担任董事。Finger先生是他于2017年创立的房地产咨询公司Alternative Sales Source，LLC的经理兼主要成员。在创立Alternative Sales Source，LLC之前，Finger先生是相关公司Hyland Bay Systems（他是该公司的首席财务官）和Hyland Bay Realty（他在2016年出售了这两家公司）的创始人和主要股东。Finger先生还创立了Cardinal Financial Services，Inc.，这是一家全国性的商业房地产抵押贷款经纪公司，他在该公司运营了20多年，直到2007年该公司被出售。Finger先生在哥伦比亚大学获得金融工商管理硕士学位，并在波士顿大学获得生物学学士学位。
- Michael H. Finger has served as a director of s since December 2021.Mr. Finger is the manager and principal member of Alternative Sales Sce, LLC, a real estate consulting firm that he founded in 2017. Prior to founding Alternative Sales Sce, LLC, Mr. Finger was active as the founder and principal shareholder of the related companies, Hyland Bay Systems, of which he was Chief Financial Officer, and Hyland Bay Realty, both of which he sold in 2016. Mr. Finger also founded Cardinal Financial Services, Inc., a national commercial real estate mortgage brokerage firm that he operated for over 20 years until its sale in 2007. Mr. Finger received his MBA in finance from Colombia University and holds a B.A. in biology from Boston University.
- Susan Snow
-
Susan Snow已同意在本次发行结束时担任董事。自2018年1月以来，Snow女士一直担任Redhorse的高级运营副总裁，这是一家咨询公司，专门从事与美国政府机构的联系和关系。此前，从2009年5月到2018年1月，她是Transitional Finance Partners的负责人。她开始了她的职业生涯，并在KPMG获得了她的注册会计师，在那里她花了4年的时间，然后离开，担任私营行业的首席财务官。
Susan Snow has served as a director of s since December 2021. From January 2018 until January 2022, Ms. Snow served as Senior VP, Operations at Redhorse, a consulting firm specializing in contacts and relationships with U.S. governmental agencies. Previoly, from May 2009 until January 2018, she was a principal at Transitional Finance Partners. Ms. Snow has also served as a director of NeoVolta Inc. since July 2022. She began her professional career and earned her CPA at KPMG, where she spent f years before leaving for a Chief Financial Officer role in private indtry. - Susan Snow已同意在本次发行结束时担任董事。自2018年1月以来，Snow女士一直担任Redhorse的高级运营副总裁，这是一家咨询公司，专门从事与美国政府机构的联系和关系。此前，从2009年5月到2018年1月，她是Transitional Finance Partners的负责人。她开始了她的职业生涯，并在KPMG获得了她的注册会计师，在那里她花了4年的时间，然后离开，担任私营行业的首席财务官。
- Susan Snow has served as a director of s since December 2021. From January 2018 until January 2022, Ms. Snow served as Senior VP, Operations at Redhorse, a consulting firm specializing in contacts and relationships with U.S. governmental agencies. Previoly, from May 2009 until January 2018, she was a principal at Transitional Finance Partners. Ms. Snow has also served as a director of NeoVolta Inc. since July 2022. She began her professional career and earned her CPA at KPMG, where she spent f years before leaving for a Chief Financial Officer role in private indtry.
- Bruce S. Urdang
-
Bruce S.Urdang已同意在本次发行结束时担任董事。Urdang先生是一名私人执业律师，自1989年以来在Bruce S.Urdang，J.D.律师事务所代表客户进行房地产和商业交易以及商业诉讼。自1989年以来，Urdang先生一直是北亚利桑那大学酒店和餐厅管理学院的教授。Urdang先生在圣约翰法学院获得法学博士学位，并在纽约州立大学Oneonta获得政治学学士学位。
Bruce S. Urdang has served as a director of s since December 2021, and is an attorney in private practice, having represented clients in real estate and biness transactions, and commercial litigation, at the Law Offices of Bruce S. Urdang, J.D. since 1989. Mr. Urdang has also been a professor at Northern Arizona University's School of Hotel and Restaurant Management since 1989. Mr. Urdang received his J.D. from St. John's School of Law and holds a B.A. in political science from the State University of New York, Oneonta. - Bruce S.Urdang已同意在本次发行结束时担任董事。Urdang先生是一名私人执业律师，自1989年以来在Bruce S.Urdang，J.D.律师事务所代表客户进行房地产和商业交易以及商业诉讼。自1989年以来，Urdang先生一直是北亚利桑那大学酒店和餐厅管理学院的教授。Urdang先生在圣约翰法学院获得法学博士学位，并在纽约州立大学Oneonta获得政治学学士学位。
- Bruce S. Urdang has served as a director of s since December 2021, and is an attorney in private practice, having represented clients in real estate and biness transactions, and commercial litigation, at the Law Offices of Bruce S. Urdang, J.D. since 1989. Mr. Urdang has also been a professor at Northern Arizona University's School of Hotel and Restaurant Management since 1989. Mr. Urdang received his J.D. from St. John's School of Law and holds a B.A. in political science from the State University of New York, Oneonta.
高管简历
中英对照 | 中文 | 英文- Timothy Warbington
Timothy Warbington自2016年2月起担任我们的董事兼首席执行官，自2011年10月起担任CMH的董事，首席执行官兼总裁。他拥有超过25年的管理经验。Warbington先生于1984年获得亚利桑那州立大学的会计学士学位。从1993年到2007年，他拥有并经营一家数百万美元的国家农产品和金融公司，年收入为5000000美元至12000000美元。在此之前，他担任一家从事国际食品贸易的英国公司的美国子公司的首席运营官。八年来，Warbington先生一直投资于生物技术行业，并作为一家上市生物技术公司的顾问提供战略和战术建议。
Timothy Warbington has served as director and as Chief Executive Officer since February 2016 and has served as a director, Chief Executive Officer and President of an affiliate of predecessor, Creative Medical Health, Inc. ("CMH") since October 2011. He has over 25 years of executive level management experience. Mr. Warbington received a Bachelor's Degree in Accounting from Arizona State University in 1984. From 1993 through 2007 he owned and operated a multi million dollar national agricultural (produce) and finance company with annual revenues of $5,000,000 to $12,000,000. Prior to that, he served as Chief Operating Officer of the U.S. subsidiary of a British firm engaged in the international food trade. For eight years, Mr. Warbington has invested in the biotechnology indtry and has provided strategic and tactical advice as a consultant to a publicly traded bio tech firm. In connection with this experience, he has built a network of scientists, physicians and executives to participate as executive officers and directors of CMH.- Timothy Warbington自2016年2月起担任我们的董事兼首席执行官，自2011年10月起担任CMH的董事，首席执行官兼总裁。他拥有超过25年的管理经验。Warbington先生于1984年获得亚利桑那州立大学的会计学士学位。从1993年到2007年，他拥有并经营一家数百万美元的国家农产品和金融公司，年收入为5000000美元至12000000美元。在此之前，他担任一家从事国际食品贸易的英国公司的美国子公司的首席运营官。八年来，Warbington先生一直投资于生物技术行业，并作为一家上市生物技术公司的顾问提供战略和战术建议。
- Timothy Warbington has served as director and as Chief Executive Officer since February 2016 and has served as a director, Chief Executive Officer and President of an affiliate of predecessor, Creative Medical Health, Inc. ("CMH") since October 2011. He has over 25 years of executive level management experience. Mr. Warbington received a Bachelor's Degree in Accounting from Arizona State University in 1984. From 1993 through 2007 he owned and operated a multi million dollar national agricultural (produce) and finance company with annual revenues of $5,000,000 to $12,000,000. Prior to that, he served as Chief Operating Officer of the U.S. subsidiary of a British firm engaged in the international food trade. For eight years, Mr. Warbington has invested in the biotechnology indtry and has provided strategic and tactical advice as a consultant to a publicly traded bio tech firm. In connection with this experience, he has built a network of scientists, physicians and executives to participate as executive officers and directors of CMH.
- Donald Dickerson
Donald Dickerson自2016年2月起担任我们的董事，首席财务官兼高级副总裁，自2014年6月起担任CMH的董事，副总裁兼首席运营官。他于1992年5月获得南加州大学的金融工商管理硕士学位。Dickerson先生曾担任多个管理和会计职位，并在技术，制造和健康科学领域的公司拥有经验。从2003年10月到2009年2月，他曾担任JP Morgan Chase公司的财务副总裁；从2011年6月到2014年5月，他还担任Medistem，Inc.的首席财务官。
Donald Dickerson has served as director and as Chief Financial Officer and Senior Vice President since February 2016, and has served as a director and as Vice President and Chief Operating Officer of CMH since June 2014. He received his Masters of Biness Administration in Finance from the University of Southern California in May 1992. Mr. Dickerson has worked in a number of management and accounting positions and has experience with companies in the technology, manufacturing and health sciences area. From October 2003 until February 2009 he was employed as a vice president for JP Morgan Chase in finance; from March 2009 until May 2014 he served as a director for GMT Ventures in finance and operations; and from June 2011 until May 2014 he also served as CFO for Medistem, Inc.- Donald Dickerson自2016年2月起担任我们的董事，首席财务官兼高级副总裁，自2014年6月起担任CMH的董事，副总裁兼首席运营官。他于1992年5月获得南加州大学的金融工商管理硕士学位。Dickerson先生曾担任多个管理和会计职位，并在技术，制造和健康科学领域的公司拥有经验。从2003年10月到2009年2月，他曾担任JP Morgan Chase公司的财务副总裁；从2011年6月到2014年5月，他还担任Medistem，Inc.的首席财务官。
- Donald Dickerson has served as director and as Chief Financial Officer and Senior Vice President since February 2016, and has served as a director and as Vice President and Chief Operating Officer of CMH since June 2014. He received his Masters of Biness Administration in Finance from the University of Southern California in May 1992. Mr. Dickerson has worked in a number of management and accounting positions and has experience with companies in the technology, manufacturing and health sciences area. From October 2003 until February 2009 he was employed as a vice president for JP Morgan Chase in finance; from March 2009 until May 2014 he served as a director for GMT Ventures in finance and operations; and from June 2011 until May 2014 he also served as CFO for Medistem, Inc.